Literature DB >> 33563458

Altered Mental Status After Esophagogastroduodenoscopy.

Joshua D Lee1, Daniel F Gallego2, James Malleis2, Kelly D Smith2, Andrew M Luks3, Desiree A Marshall2.   

Abstract

CASE
PRESENTATION: A 79-year-old man with medical history of atrial fibrillation and esophageal cancer status post trans-hiatal esophageal resection and chemotherapy presented with altered mental status after outpatient esophagogastroduodenoscopy (EGD). One month before presentation, the patient was seen at another hospital with severe anemia and melena requiring transfusion of multiple units of RBCs. No endoscopy was performed during that admission, but his anticoagulation was held. After follow-up with his oncologist, he was referred for outpatient endoscopy. His esophagogastroduodenoscopy demonstrated an intact esophagogastric anastomosis as well as two gastric ulcers with no stigmata of recent bleeding. The patient was discharged to home in good condition with normal mental status. Several hours later, he developed a deteriorating level of consciousness, prompting presentation to the hospital.
Copyright © 2020 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2021        PMID: 33563458      PMCID: PMC8438161          DOI: 10.1016/j.chest.2020.08.2098

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  10 in total

1.  Life-threatening GI hemorrhage caused by atrioesophageal fistula: a rare complication after catheter ablation for atrial fibrillation.

Authors:  Michael J Baker; Purvi C Panchal; Patricia A Allenby
Journal:  Gastrointest Endosc       Date:  2010-05-23       Impact factor: 9.427

Review 2.  Neurological manifestations of atrio-esophageal fistulas from left atrial ablation.

Authors:  J Finsterer; C Stöllberger; T Pulgram
Journal:  Eur J Neurol       Date:  2011-03-22       Impact factor: 6.089

3.  Endoscopy - related bacteremia. Incidence of positive blood cultures after endoscopy of upper gastrointestinal tract.

Authors:  M H Mellow; R J Lewis
Journal:  Arch Intern Med       Date:  1976-06

4.  Adverse events of upper GI endoscopy.

Authors:  Tamir Ben-Menachem; G Anton Decker; Dayna S Early; Jerry Evans; Robert D Fanelli; Deborah A Fisher; Laurel Fisher; Norio Fukami; Joo Ha Hwang; Steven O Ikenberry; Rajeev Jain; Terry L Jue; Khalid M Khan; Mary L Krinsky; Phyllis M Malpas; John T Maple; Ravi N Sharaf; Jason A Dominitz; Brooks D Cash
Journal:  Gastrointest Endosc       Date:  2012-10       Impact factor: 9.427

5.  Food embolus.

Authors:  P Reynolds; F O Walker; J Eades; J D Smith; P E Lantz
Journal:  J Neurol Sci       Date:  1997-08       Impact factor: 3.181

6.  Rapid detection and successful treatment of esophageal perforation after radiofrequency ablation of atrial fibrillation: lessons from five cases.

Authors:  Nikolaos Dagres; Hans Kottkamp; Christopher Piorkowski; Nicolas Doll; Friedrich Mohr; Marc Horlitz; Dimitrios Th Kremastinos; Gerhard Hindricks
Journal:  J Cardiovasc Electrophysiol       Date:  2006-09-20

Review 7.  Transmission of infection by flexible gastrointestinal endoscopy and bronchoscopy.

Authors:  Julia Kovaleva; Frans T M Peters; Henny C van der Mei; John E Degener
Journal:  Clin Microbiol Rev       Date:  2013-04       Impact factor: 26.132

8.  Aortoesophageal fistula: recognition and diagnosis in the emergency department.

Authors:  R L Heckstall; J E Hollander
Journal:  Ann Emerg Med       Date:  1998-10       Impact factor: 5.721

9.  Challenges and limitations in the diagnosis of atrioesophageal fistula.

Authors:  Francis J Ha; Hui-Chen Han; Prashanthan Sanders; Andrew W Teh; David O'Donnell; Omar Farouque; Han S Lim
Journal:  J Cardiovasc Electrophysiol       Date:  2018-04-23

10.  CT radiographic findings: atrio-esophageal fistula after transcatheter percutaneous ablation of atrial fibrillation.

Authors:  Angelo P Malamis; Kevin J Kirshenbaum; Surya Nadimpalli
Journal:  J Thorac Imaging       Date:  2007-05       Impact factor: 3.000

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.